Journal of Cellular and Molecular Pharmacology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • J Cell Mol Pharmacol 8: 202,

Drug Receptor-Effector Coupling: Implications for Drug Discovery and Therapeutic Development

Haotian Ehsan*
Public Health Department, Mizan-Tepi University, Ethiopia
*Corresponding Author : Haotian Ehsan, Public Health Department, Mizan-Tepi University, Ethiopia, Email: ehsantian@yahoo.com

Received Date: Feb 01, 2024 / Published Date: Feb 29, 2024

Abstract

The interaction between drugs and their molecular targets, known as drug receptor-effector coupling, lies at the heart of pharmacology and therapeutic development. This article provides a comprehensive overview of drug receptor-effector coupling, highlighting the underlying mechanisms, implications for drug discovery, and therapeutic applications. By elucidating the dynamic interplay between drugs, receptors, and downstream effectors, we aim to enhance understanding of drug action and facilitate the development of more efficacious and targeted therapeutics.

Citation: Haotian E (2024) Drug Receptor-Effector Coupling: Implications for DrugDiscovery and Therapeutic Development. J Cell Mol Pharmacol 8: 202.

Copyright: © 2024 Haotian E. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top